Company Profile

Axon Instruments Inc
Profile last edited on: 7/8/14      CAGE: 0WMR5      UEI:

Business Identifier: Novel devices and software for drug discovery. Cell-Based Screening: cell-based pharmaceutical screening using high-resolution fluorescence imaging and electrophysiology (patch and voltage clamp) Microarray Analysis
Year Founded
1984
First Award
1986
Latest Award
1986
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3280 Whipple Road
Union City, CA 94587
   (510) 675-6200
   ceo@axon.com
   www.axon.com
Location: Single
Congr. District: 15
County: Alameda

Public Profile

In March 2004, Axon Instruments was acquired by Molecular Devices, itslef an SBIR involved firm. Axon Instruments, Inc., a California incorporated company, trading on the Australian Stock Exchange (ASX) under the symbol AXN. Axon Instruments, Inc. was founded to design, manufacture and market instrumentation and software for cellular neurosciences and biophysical research. Today, the company is in low-noise signal amplification instruments and related data acquisition and analysis products for cellular neuroscience. The firm's Axoclamp and Axopatch series microelectrode amplifiers and Digidata series analog-to-digital conversion systems have the lowest instrumentation noise of any competing products. Their MultiClamp microelectrode amplifier incorporates more powerful features than any other amplifier available, all made accessible by an automated user interface. Axon manufacture video microscopy hardware and software for the life sciences. Products support image acquisition, processing and analysis, and feature high-precision device control for cellular flourescence imaging. Systems integrator for complete imaging systems - functional genomics and high-throughput screening (HTS)

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
100-149
Revenue Range
10M-15M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
15-19

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1986 1 NIH $50,000
Project Title: A high performance patch clamp

Key People / Management

  Alan S Finkel -- President

Company News

There are no news available.